Navigation Links
Duska Therapeutics Submits Phase 3 ATPace(TM) Protocol to FDA for Comment
Date:7/23/2008

under Section 505(b)(2)".

Dr. Amir Pelleg, Duska's President and Chief Scientific Officer, stated, "I expect that the Special Protocol Assessment by the FDA would facilitate the completion of the clinical development of ATPace(TM) in a timely fashion".

About ATPace(TM)

ATPace(TM) (adenosine triphosphate injection) is a proposed product for the termination of paroxysmal supraventricular tachycardia (PSVT). The bradycardic effect of ATP, in particular its blockade of atrio-ventricular nodal (AVN) conduction, has been shown to effectively terminate re-entrant PSVT involving the AV node. Adenosine is the only approved competition in the U.S. Duska believes that the initial dose of ATPace(TM) will be significantly more efficacious than the initial labeled dose of adenosine in terminating PSVT. While ATP and adenosine both inhibit AVN conduction, ATPace(TM) is believed to have a second mechanism of action to stimulate vagally-mediated suppression of AVN conduction. Injectable formulations of ATP have been approved in Europe for over 50 years as safe and efficacious treatments for PSVT. Duska has completed Phase 1 and 2 clinical trials in diagnosing bradycardia, and has acquired more than 1,000 patients records from other clinical trials. Duska has met with the FDA to ascertain which additional requirements might be necessary for marketing approval of ATPace(TM). Duska plans a 505(b)(2) NDA filing route for approval.

About Duska Therapeutics, Inc.

Duska Therapeutics, Inc. (Duska) is a specialty pharmaceutical company that develops new cardiovascular and pulmonary medicines based upon the emerging new pharmacology of adenosine triphosphate (ATP) and nitric oxide (NO). These two molecules play critical roles in cellular metabolism and signal transduction, the manipulation of which by several pharmaceuticals constitute novel therapeutic modalities for the treatment of major cardiovascular disorders. Duska is developing a portfolio of investi
'/>"/>

SOURCE Duska Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Duska Therapeutics Obtains Standard & Poors Listing
2. Roche starts acquisition process of ARIUS to gain access to new screening platform for antibody therapeutics
3. CV Therapeutics to Announce 2008 Second Quarter Financial Results on Thursday, July 31, 2008
4. Lorus Therapeutics Reports Fourth Quarter Results for Fiscal Year 2008
5. Zenobia Therapeutics, Inc. Begins Operations as a Fragment-Based Lead Discovery Company
6. Northwest Biotherapeutics to Present at Next Generation Vaccine Conference
7. Organizational Changes at Silence Therapeutics
8. Genzyme Corporation and PTC Therapeutics Announce Collaboration on Small Molecule for Genetic Diseases
9. Arno Therapeutics Announces New Ticker Symbol
10. Lorus Therapeutics Receives $600 Thousand From Escrow Account
11. Silence Therapeutics Announces Successful Opposition of Glover Patent
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/5/2008)...test pilots push planes to explore their limits, r...and Technology (NIST) are probing the newest micro...curacy at the nanoscale. Better nanoscale measurem...ing production in the semiconductor and nanomanufa...logy uses helium ions to generate the signal used ...
(Date:9/5/2008)...e Food & Drug Administration (FDA) issued in July ...port acknowledged that nanoscale materials potenti... by the agency and that those materials present ch...elevant to product safety and effectiveness may ch...icipating the potential for rapid commercializatio...
(Date:9/5/2008)...us, gold is only valuable if we possess it in larg...le isn,t the case for those interested in exploiti...ariety of chemical reactions, including the oxidat...s carbon dioxide at room temperatures. That proces...e effectiveness of catalytic converters that clean...
(Date:9/5/2008)...ept. 5 /- Gen-Probe Incorpo...mpany will present at the Morgan,Stanley Global He...r 9,2008 at approximately 2:45 p.m. Eastern Time....and may be accessed through a link on the investor...n-probe.com . The webcast,will be available for 30...
Breaking Biology Technology:NIST studies how new helium ion microscope measures up 2Nanotechnology and the FDA: size matters 2NIST and partners identify tiny gold clusters as top-notch catalysts 2Gen-Probe to Webcast Presentation at the Morgan Stanley Global Healthcare Unplugged Conference 2
... Hartford, Wis. - Techware , a Hartford-based t... complete a wireless broadband network in the Wash...pany also has visions of serving other areas of th...ulting services to businesses, will continue a wir...ern half of Germantown with three antennas install...
... The world of financing life-science companies h...s it difficult for new and emerging companies, as ...se money. The rules have changed! , ,Let,s start...ich is how many investors used to make money (thos...used this as an exit). There used to be periods of...
... Fitchburg, Wis. - Under pressure from expiring ...nding and developing new drugs, big pharmaceutical...biotechnology companies to outsource specific scie...s opportunities. , ,At a recent meeting of the Wi...on , pharmaceutical company representatives from ...
... Wauwatosa, Wis. - A Medical College of Wiscons...work to isolate, grow, and identify a new type of ...ls, appears to have the potential for diversificat... found in the bulge of hair follicles. , ,Accordi...ified the "molecular signature" of epidermal neura...
Other Biology Technology:Techware revives broadband project 2Financing life science: The ongoing saga 2Financing life science: The ongoing saga 3Financing life science: The ongoing saga 4Financing life science: The ongoing saga 5Financing life science: The ongoing saga 6Big pharma seeks Wisconsin biotech partnerships 2Medical College team seeks stem cell patent 2Medical College team seeks stem cell patent 3
(Date:9/4/2008)...are numerous plant-parasitic nematodes in the worl...est part of an estimated $157 billion in agricultu...l worms that burrow into plant roots and feed off ...rchers have contributed to the release of the anno...des: Meloidogyne incognita -- the southern root-...
(Date:9/4/2008)... 2008 As the anniversary of the September 11 atta...) has issued a new podcast describing an array of ...tional security. The podcast is the sixth episode...olutions )series. , With new episodes posted twi...oblems facing society in the 21st Century, and exp...
(Date:9/4/2008)...A team including researchers at the HudsonAlpha In...leagues from a number of other organizations, toda...riation in the brain cancer glioblastoma. These re...TCGA) research network, a collaborative effort fun...nal Human Genome Research Institute of the Nationa...
(Date:9/4/2008)...s and a pathology company have joined forces to de... reveal a way to predict premature birth with grea...niversity of Newcastle and Symbion Pathology are c...ng and pathology to develop a computer program to ...ut 17,000 pre-term births occur in Australia each ...
Breaking Biology News(10 mins):ISU researchers help map first plant-parasitic nematode genome sequence 2New 'chemical radar' among national security innovations in ACS podcast 2New 'chemical radar' among national security innovations in ACS podcast 3Collaboration between researchers yields more comprehensive portrait of brain cancer 2World-first to predict premature births 2Walter Reed Anniversary Exposes More McCain Double Talk 12158 1Walter Reed Anniversary Exposes More McCain Double Talk 12158 2Walter Reed Anniversary Exposes More McCain Double Talk 12158 3Portable Computer Devices Can Aid Exercise Programs 12154 1Portable Computer Devices Can Aid Exercise Programs 12154 2Alcoholics underestimate the risk of bleeding 12151 1One Drink May Help Heart But Two Is Too Many 12147 1One Drink May Help Heart But Two Is Too Many 12147 2
...gonomics (HF/E) researchers at the University of U...e it possible for anyone ?even those with no emerg...ons for victims of sudden cardiac arrest. The jus...ders with guidance and information on how to admin...ctim. The researchers will present their work at t...
...USDA Forest Service (FS) scientists from the FS So...angle Park, NC, along with colleagues from Duke Un...of the National Academy of Science (PNAS) that pro...espond to increasing atmospheric concentrations of...iving climate change. , Building on preliminary...
...hly drug-resistant tuberculosis are emerging and a...read globally, says an editorial in this week,s BM... to implement effective tuberculosis control strat...control practices have been inadequate. , Resear...ad of these highly drug resistant strains of tuber...
... which the circulating strains of influenza showed... the traditional killed-virus flu shot was found t...adults. The live attenuated-virus nasal spray vacc...e. , Both outcomes were determined by laboratory c...igan study found. , Earlier studies had suggeste...
Other Biology News:Soil nutrition affects carbon sequestration in forests 2World-wide warning of highly drug-resistant tuberculosis 2Flu shot effective against drifted influenza, nasal spray vaccine less so 2Flu shot effective against drifted influenza, nasal spray vaccine less so 3
Compound(s) tested through a broad panel of 38 ligand binding and enzyme assays targeting the Central Nervous System. Used to determine selectivity and potential CV/Renal liabilities of compounds.
...• Human serum is obtained from normal human d...uman Immunodeficiency Virus Antigen (s) (HIV-1Ag),...HIV 1/2), Hepatitis C Virus (HCV), and Nonreactive...eactive by a screening test for syphilis. Serum is...
Compound(s) screened through any number of client selected assays. Client also selects number of concentrations and replicates.
Values of steady state parameters for enzyme activities are determined.
Biology Products: